Literature DB >> 8073469

Focal ischemia causes an extensive induction of immediate early genes that are sensitive to MK-801.

Y Collaço-Moraes1, B S Aspey, J S de Belleroche, M J Harrison.   

Abstract

BACKGROUND AND
PURPOSE: There is strong evidence to implicate glutamate in the cerebral damage caused by ischemia. In this study we investigated the role of glutamate receptors in mediating effects of middle cerebral artery occlusion (MCAO) on immediate early gene expression in the rat by quantitation of mRNA levels.
METHODS: The effect of MCAO on the induction of immediate early genes was studied in five regions, both ipsilateral and contralateral to the occlusion: the "core" ischemic area of the cortex in the central region of the middle cerebral artery territory, the surrounding area, frontal cortex, occipital cortex, and hippocampus. Levels of c-fos, c-jun, zif-268, and krox-20 mRNA were measured by Northern and slot blot analysis.
RESULTS: A large induction of c-fos mRNA was obtained in all four cortical regions ipsilateral to the occlusion, with the greatest effect detected in the core area. Little effect was detected in the ipsilateral hippocampus and in all contralateral regions. Pretreatment with MK-801 (3 mg/kg) largely inhibited the induction of c-fos mRNA, indicating that the induction was mediated through an N-methyl-D-aspartate subtype of glutamate receptor. MCAO also produced a significant induction of c-jun and zif-268 mRNA in ipsilateral cortical regions.
CONCLUSIONS: These results indicate that MCAO causes a profound modulation of the expression of multiple genes in an extensive area of cerebral cortex extending beyond the immediate area supplied by the middle cerebral artery. The marked effect of MK-801 indicates the potential importance of glutamate antagonists in restricting the widespread deleterious effects of glutamate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073469     DOI: 10.1161/01.str.25.9.1855

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Loss of c/EBP-beta activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons.

Authors:  Marc W Halterman; Christopher De Jesus; David A Rempe; Nina F Schor; Howard J Federoff
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

2.  Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

Authors:  Tzipora Shoshani; Alexander Faerman; Igor Mett; Elena Zelin; Tamar Tenne; Svetlana Gorodin; Yana Moshel; Shlomo Elbaz; Andrei Budanov; Ayelet Chajut; Hagar Kalinski; Iris Kamer; Ada Rozen; Orna Mor; Eli Keshet; Dena Leshkowitz; Paz Einat; Rami Skaliter; Elena Feinstein
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Down-regulated Na(+)/K(+)-ATPase activity in ischemic penumbra after focal cerebral ischemia/reperfusion in rats.

Authors:  Hao Huang; Yang-Mei Chen; Fei Zhu; Shi-Ting Tang; Ji-Dong Xiao; Lv-Li Li; Xin-Jing Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  The Effects of Glutamate NMDA Receptor Antagonist MK-801 on Gastrointestinal Motility after Middle Cerebral Artery Occlusion in Rats.

Authors:  Nasir Hussin Ameer; Jae Hee Lee; Myoung Ae Choi; Guang-Shi Jin; Min Sun Kim; Byung Rim Park
Journal:  Korean J Physiol Pharmacol       Date:  2010-06-30       Impact factor: 2.016

5.  Effect of transcranial magnetic stimulation on the expression of c-Fos and brain-derived neurotrophic factor of the cerebral cortex in rats with cerebral infarct.

Authors:  Xiaoqiao Zhang; Yuanwu Mei; Chuanyu Liu; Shanchun Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

6.  A new role for downstream Toll-like receptor signaling in mediating immediate early gene expression during focal cerebral ischemia.

Authors:  Bolanle M Famakin; Yongshan Mou; Kory Johnson; Maria Spatz; John Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-04       Impact factor: 6.200

7.  Treatment with the snail peptide CGX-1007 reduces DNA damage and alters gene expression of c-fos and bcl-2 following focal ischemic brain injury in rats.

Authors:  A J Williams; G Ling; R Berti; J R Moffett; C Yao; X M Lu; J R Dave; F C Tortella
Journal:  Exp Brain Res       Date:  2003-08-29       Impact factor: 1.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.